Share this page

 SIERRA ONCOLOGY — 1824703

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

1824703

Registration number

TMA1059415

Type(s)

Word

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2017-02-27

Registered

2019-10-17

Registration Expiry Date

2029-10-17

Current owner

GlaxoSmithKline LLC
Corporation Service Company
251 Little Falls Drive
Wilmington, DE 19808
UNITED STATES OF AMERICA

Agent

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.
1, Place Ville Marie
Suite 2700, Montreal
QUEBEC H3B1R1

Registered Owner

Sierra Oncology LLC
Corporation Service Company
251 Little Falls Drive
Wilmington, DE 19808
UNITED STATES OF AMERICA

Applicant

Sierra Oncology LLC
Corporation Service Company
251 Little Falls Drive
Wilmington, DE 19808
UNITED STATES OF AMERICA

Documents

View documents

Index headings

  • SIERRA ONCOLOGY

Goods (Nice class & Statement)

(1) Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of cancer, namely blood cancers and solid tumors; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of cancer related diseases, namely anemia, thrombocytopenia, neutropenia, fatigue; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of disorders and infections of the endocrine system, namely growth and thyroid disorders; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Biological, chemical and pharmaceutical products, preparations and compounds for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue or organ implantation.

Classification data

Disclaimer

The classification data is provided for information and searching purposes only. CIPO does not warrant the accuracy of the classes assigned to the trademark. This data has no legal value of any kind.

5 - Pharmaceuticals and herbicides

Claims

  • Proposed Use in CANADA

Recordals (known also as Footnotes)


Owner Address Change / Changement d'adresse du propriétaire
DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-02-08
CHANGE IN TITLE / CHANGEMENT EN TITRE:
TYPE OF CHANGE / GENRE DE CHANGEMENT: Name and Address / Nom et adresse
DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-02-16
DATE OF CHANGE / DATE DE CHANGEMENT: 2022-11-30
COMMENTS / COMMENTAIRES: FROM/DE: SIERRA ONCOLOGY INC.
TO/A: Sierra Oncology LLC
CHANGE IN TITLE / CHANGEMENT EN TITRE:
TYPE OF CHANGE / GENRE DE CHANGEMENT: Assignment / Cession
DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-03-20
DATE OF CHANGE / DATE DE CHANGEMENT: 2023-03-15
COMMENTS / COMMENTAIRES: FROM/DE: Sierra Oncology LLC
TO/A: GlaxoSmithKline LLC

Action History

Actions
Action Action date Due date Comments
Filed 2017-02-27
Created 2017-02-27
Formalized 2017-03-01
Search Recorded 2017-12-19
Examiner's First Report 2017-12-19 2018-06-19
Extension of Time 2018-06-26 2018-12-19 Request Letter Date: 2018/06/18
Approval Notice Sent 2019-03-14 2019-04-11
Approved 2019-05-02 APPROVED BY PROGRAM EX200M1
Advertised 2019-05-22 Vol.66 Issue 3369
Registration Pending 2019-08-14
Registration Fee Notice Sent 2019-08-14 2020-02-14
Registered 2019-10-17 2029-10-17
Assignment Correspondence Created 2023-02-01
Amendment to Registration 2023-02-08 Address/address
Amendment to Registration 2023-02-16 Name and Address/Nom et address
Change of Title Registered 2023-03-20 Assignment/Cession
Report a problem on this page
Date modified: